Subscribe To
CHGX / ChitogenX highlights milestones achieved in fiscal year
ChitogenX Inc has reported its financial results for the fourth quarter and fiscal year ended January 31, 2023, highlighting some milestones achieved during the period. The company successfully completed the initial portion of its US Phase I/II ORTHO-R rotator cuff tear repair clinical trial in November 2022 with no safety issues reported.
Read More
Posted: Jun 1 2023, 08:46
Author Name: Proactive Investors
Views: 110262
CHGX News
By Proactive Investors
June 1, 2023
ChitogenX highlights milestones achieved in fiscal year
ChitogenX Inc has reported its financial results for the fourth quarter and fiscal year ended January 31, 2023, highlighting some milestones achiev more_horizontal